FDA Inspection 633391 — New York Blood Center Inc
The FDA completed an inspection of New York Blood Center Inc on December 4, 2009 in St. Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 4, 2009
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- St. Paul, MN (United States)